Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose mass balance and pharmacokinetics study of intravenous 14C-GSK2251052 in healthy adult men
NL-OMON36141Active, not recruiting
- Sponsor
- GSK
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of epetraborole in bacterial disease, sponsored by GSK. Primary endpoints: Radiokinetics, Pharmacokinetics and 3 more. Started Apr 2011; status: active, not recruiting.
02
Drugs
epetraborole
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON36141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36141.